SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-090519
Filing Date
2023-08-11
Accepted
2023-08-11 16:31:18
Documents
6
Effectiveness Date
2023-08-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2323176d1_s8.htm S-8 83490
2 EXHIBIT 5.1 tm2323176d1_ex5-1.htm EX-5.1 10661
3 EXHIBIT 23.2 tm2323176d1_ex23-2.htm EX-23.2 6017
4 EX-FILING FEES tm2323176d1_ex-filingfees.htm EX-FILING FEES 11743
5 GRAPHIC tm2323176d1_ex5-1img001.jpg GRAPHIC 3557
6 GRAPHIC tm2323176d1_ex23-2img001.jpg GRAPHIC 2321
  Complete submission text file 0001104659-23-090519.txt   121571
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273936 | Film No.: 231164605
SIC: 2836 Biological Products, (No Diagnostic Substances)